TNFRSF8 and anaplastic large cell lymphoma: The BV + CHP (Cyclophosphamide, Hydroxyrubicin, Prednisone) regimen has demonstrated superior progression-free survival and response rates compared to conventional CHOP (Cyclophosphamide, Hydroxyrubicin, Oncovin, Prednisone) chemotherapy, making it the preferred regimen for CD30-positive ALCL [9,10].